Hyperlipoproteinemia in renal insufficiency

Nephron
C C Heuck, E Ritz

Abstract

In uremic patients, hyperlipoproteinemia is common, but its role as a risk factor in atherogenesis remains controversial. The main abnormality appears to be diminished catabolism of lipoproteins in the face of unchanged or low hepatic synthesis. The relation of diminished catabolism to reduced postheparinlipolytic activity and selective deficiency of hepatic triglyceride lipase remains to be established. Hyperlipoproteinemia in uremic patients, most commonly of the type IV variety, responds to dietary methods (reduction of carbohydrate content, increase in P/S ratio) or pharmacological intervention. Guidelines for therapy remain controversial in view of the uncertainty about the pathogenic role of hyperlipoproteinemia in atherogenesis.

Citations

Oct 1, 1988·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·U QuerfeldR N Fine
Dec 1, 1993·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·U Querfeld
Jan 1, 1981·International Urology and Nephrology·P HirszelM Lasrich
Mar 5, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·P GambertP Padieu
Dec 1, 1990·Baillière's Clinical Endocrinology and Metabolism·C D Short, P N Durrington
Apr 1, 1992·Australian and New Zealand Journal of Medicine·S C Greaves, D N Sharpe
Jun 11, 2010·Indian Journal of Nephrology·M PrakashM Supriya
Aug 28, 2012·Journal of Laboratory Physicians·Lorenzo GordonMarilyn Lawrence-Wright
Mar 5, 1990·Klinische Wochenschrift·P WeidmannC Beretta-Piccoli
Jan 1, 1991·Clinical and Experimental Hypertension. Part A, Theory and Practice·B S HuangG L Wright
Oct 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M A JosephsonA Dasgupta
May 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M Zarama, L Raij
Jan 1, 1995·Kidney International·A Kautzky-WillerR Prager
Jan 1, 1983·Kidney International·H von BaeyerM Kessel
Feb 1, 1985·Kidney International·J B RoulletT Drueke
Feb 1, 1982·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·F Marzulli, H C Maguire
Dec 1, 1981·Acta Pathologica Et Microbiologica Scandinavica. Section C, Immunology·T Wessel-Aas
Dec 1, 1981·Acta Pathologica Et Microbiologica Scandinavica. Section C, Immunology·T Wessel-Aas
Feb 1, 1993·Metabolism: Clinical and Experimental·R J Shapiro
Jan 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D O'NealJ Best

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.